THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110070
- Institute of Liver & Biliary Sciences
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
'Inclusion Criteria:
- Subjects aged ≥ 18 years.
- Patients with alcohol related liver disease (severe alcoholic hepatitis and decompensated cirrhosis)
- Patients tolerating enteral nutrition.
Exclusion Criteria:
- Active ongoing Gastrointestinal bleed.
- Unresolved sepsis
- Allergy to soya oil, eggs, peanuts or other ingredients of intralipid.
- Co-morbidities like Diabetes mellitus, hyperlipidemia, Coronary Artery Disease (CAD) and hypothyroidism.
- Renal failure (S.creatinine > 1.5mg %)
- Pregnancy
- Patients on high inotropic support (requiring more than 1 inotropic support)
- Refusal to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Parenteral Nutrition
Soybean based lipid emulsion
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effect of intravenous lipid on monocytes counts.
Time Frame: 3 days
|
3 days
|
|
Effect of intravenous lipid on neutrophils counts.
Time Frame: 3 days
|
3 days
|
|
Effect of intravenous lipid on macrophages count.
Time Frame: 3 days
|
3 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Influence of lipid infusion on TEG (Thromboelastography)
Time Frame: 3 days
|
3 days
|
|
Influence of lipid infusion on TNF-α (Tumor Necrosis Factor).
Time Frame: 3 days
|
3 days
|
|
Influence of lipid infusion on interleukin levels (IL-6, IL-10).
Time Frame: 3 days
|
3 days
|
|
Influence of lipid infusion on PT/INR
Time Frame: 3 days
|
3 days
|
|
Influence of lipid infusion on PTT.
Time Frame: 3 days
|
3 days
|
|
Influence of lipid infusion on liver parameters.
Time Frame: 3 days
|
3 days
|
|
Influence of lipid infusion on arterial ammonia.
Time Frame: 3 days
|
3 days
|
|
Influence of lipid infusion on renal parameters.
Time Frame: 3 days
|
3 days
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Influence of lipid infusion on nitrogen balance
Time Frame: 3 days
|
nitrogen balance would be calculated by 24 hours urinary blood urea nitrogen estimation.
|
3 days
|
|
Metabolic tolerance of lipid infusion.
Time Frame: 3 days
|
Metabolic tolerance would be assessed by effect on serum triglycerides level ,serum free fatty acid level,arterial lactate level.
|
3 days
|
|
Effect of lipid infusion on Oxidative stress.
Time Frame: 3 days
|
Oxidative stress would be determine by using urinary isoprostane test.
|
3 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ILBS-lipid infusion-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.